Cite
APA Citation
Tang, H., Kimmel, S. E., Hernandez, I., Brooks, M. M., Cusi, K., Smith, S. M., Shi, W., Winterstein, A. G., Magnani, J. W., & Guo, J. (2022). are novel glucose‐lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta‐trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment. Diabetes, obesity & metabolism, 24(1), 154–159. http://access.bl.uk/ark:/81055/vdc_100147043735.0x000032